Chantibody Therapeutics
PrivateCompany Overview
Chantibody Therapeutics is a biotechnology company that develops an AI-guided antibody discovery platform for creating diverse biologics, including multispecific antibodies, CAR-T cell therapies, and mRNA therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Chantibody Therapeutics Comparables
Compare Chantibody Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aureka | 85% | |
| Infinimmune | 83% | |
| Abzyme Therapeutics | 79% |
Chantibody Therapeutics Funding Rounds
Historical fundraising activity
Chantibody Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Chantibody Therapeutics's valuation, stock price, and market status.
Is Chantibody Therapeutics a public or private company?
Chantibody Therapeutics is a private company.
What is the current stock price of Chantibody Therapeutics?
Chantibody Therapeutics is a private company with no public stock price. Caplight tracks Chantibody Therapeutics's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Chantibody Therapeutics worth (valuation)?
Valuation information for Chantibody Therapeutics is not publicly available.
Can I buy Chantibody Therapeutics stock?
Chantibody Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Chantibody Therapeutics's last funding round?
Funding round information for Chantibody Therapeutics is not publicly available.
Who are the main investors in Chantibody Therapeutics?
Investor information for Chantibody Therapeutics is not publicly disclosed.
Will Chantibody Therapeutics IPO soon?
No public IPO plans have been announced for Chantibody Therapeutics.
How can I track Chantibody Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Chantibody Therapeutics's secondary market activity and sign up for updates.